RedHawk Holdings Corp. said it now holds 75% of common shares of privately-held generic maker EcoGen Europe LTD.
Louisiana-based RedHawk and its unit RedHawk Pharma UK Ltd. completed a share transfer agreement with U.K.-based Scarlett Pharma Ltd and its affiliate.
Under the deal, Scarlett and its unit transferred about $545,000 worth of preference shares and 75% of common shares in EcoGen to RedHawk.
RedHawk said it was evaluating the possibility of converting its EcoGen preference shares into additional common shares to further raise its common stock ownership in EcoGen.
